Amr Molla, Muhammad Tobaiqi, Hossein Elbadawy, Raed Jannadi, Heba Eltahir, Emad Albadawi, Naweed Alzaman, Mohammed Aloufi, Mekky Abouzied, Muayad Albadrani
Introduction: Warts, benign skin growths caused by various human papillomavirus strains, are categorized as genital and non-genital. Non-genital warts often lack noticeable symptoms but can lead to psychological distress due to factors like embarrassment. Traditional treatments, including physical and chemical methods, show limitations, prompting the exploration of novel approaches like intralesional immunotherapy. The clinical challenge lies in selecting the most effective modality.
Objective: In our study, we used the network meta-analysis (NMA) as a statistical tool to explore the most effective intralesional immunotherapy interventions.
Methods: Comprehensive searches of Web of Science, PubMed, Cochrane, and Scopus databases were conducted until December 2023. Eligible studies were analyzed for outcomes presented as risk ratios (RRs) with 95% confidence intervals (CI). Treatments were ranked using the P-score in an NMA performed with R software.
Results: We included 68 RCTs in our study. For complete response, needling showed a significant difference compared to Candida albicans antigen (RR= 0.13, 95% CI [0.02; 0.99]) and Mw (RR= 0.12, 95% CI [0.02; 0.94]). In overall response, both bleomycin and furosemide with digoxin were significant compared to autoimplantation (RR= 0.46, 95% CI [0.24; 0.88]) and (RR= 0.40, 95% CI [0.18; 0.91]) respectively. Similarly, both were significant compared to cryotherapy (RR= 0.45, 95% CI [0.27; 0.76]) and (RR= 0.40, 95% CI [0.19; 0.82]) respectively.
Conclusion: This NMA indicates needling, furosemide with digoxin, and PBP antigen stimulants as effective for non-genital warts, surpassing traditional treatments in complete and overall response. Direct comparisons in future research are warranted to confirm their superiority.
导言:疣是由各种人类乳头瘤病毒引起的良性皮肤增生,分为生殖器疣和非生殖器疣。非生殖器疣通常没有明显症状,但会因尴尬等因素导致心理困扰。传统的治疗方法,包括物理和化学方法,都有其局限性,这促使人们开始探索新的方法,如局部免疫疗法。临床面临的挑战在于如何选择最有效的方法:在研究中,我们使用网络荟萃分析(NMA)作为统计工具,探索最有效的内部免疫疗法干预方法:方法:对 Web of Science、PubMed、Cochrane 和 Scopus 数据库进行了全面检索,直至 2023 年 12 月。对符合条件的研究结果进行了分析,结果显示为风险比(RR)和95%置信区间(CI)。在使用 R 软件进行的 NMA 中,使用 P 分数对治疗进行排序:我们在研究中纳入了 68 项研究。在完全应答方面,针刺与白色念珠菌抗原(RR= 0.13,95% CI [0.02; 0.99])和 Mw(RR= 0.12,95% CI [0.02; 0.94])相比有显著差异。在总体反应方面,博莱霉素和呋塞米加地高辛与自体植入相比均有显著性差异,分别为(RR= 0.46,95% CI [0.24;0.88])和(RR= 0.40,95% CI [0.18;0.91])。同样,与冷冻疗法(RR= 0.45,95% CI [0.27;0.76])和(RR= 0.40,95% CI [0.19;0.82])相比,这两种疗法的疗效也很显著:该 NMA 表明针刺、呋塞米加地高辛和 PBP 抗原刺激剂对非生殖器疣有效,在完全反应和总体反应方面超过了传统疗法。在未来的研究中,有必要进行直接比较,以确认它们的优越性。
{"title":"Comparative Analysis of Intralesional Immunotherapy and Conventional Treatments for Non-Genital Warts: A Systematic Review and Network Meta-Analysis.","authors":"Amr Molla, Muhammad Tobaiqi, Hossein Elbadawy, Raed Jannadi, Heba Eltahir, Emad Albadawi, Naweed Alzaman, Mohammed Aloufi, Mekky Abouzied, Muayad Albadrani","doi":"10.5826/dpc.1403a215","DOIUrl":"10.5826/dpc.1403a215","url":null,"abstract":"<p><strong>Introduction: </strong>Warts, benign skin growths caused by various human papillomavirus strains, are categorized as genital and non-genital. Non-genital warts often lack noticeable symptoms but can lead to psychological distress due to factors like embarrassment. Traditional treatments, including physical and chemical methods, show limitations, prompting the exploration of novel approaches like intralesional immunotherapy. The clinical challenge lies in selecting the most effective modality.</p><p><strong>Objective: </strong>In our study, we used the network meta-analysis (NMA) as a statistical tool to explore the most effective intralesional immunotherapy interventions.</p><p><strong>Methods: </strong>Comprehensive searches of Web of Science, PubMed, Cochrane, and Scopus databases were conducted until December 2023. Eligible studies were analyzed for outcomes presented as risk ratios (RRs) with 95% confidence intervals (CI). Treatments were ranked using the P-score in an NMA performed with R software.</p><p><strong>Results: </strong>We included 68 RCTs in our study. For complete response, needling showed a significant difference compared to Candida albicans antigen (RR= 0.13, 95% CI [0.02; 0.99]) and Mw (RR= 0.12, 95% CI [0.02; 0.94]). In overall response, both bleomycin and furosemide with digoxin were significant compared to autoimplantation (RR= 0.46, 95% CI [0.24; 0.88]) and (RR= 0.40, 95% CI [0.18; 0.91]) respectively. Similarly, both were significant compared to cryotherapy (RR= 0.45, 95% CI [0.27; 0.76]) and (RR= 0.40, 95% CI [0.19; 0.82]) respectively.</p><p><strong>Conclusion: </strong>This NMA indicates needling, furosemide with digoxin, and PBP antigen stimulants as effective for non-genital warts, surpassing traditional treatments in complete and overall response. Direct comparisons in future research are warranted to confirm their superiority.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11313703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sümeyre Seda Ertekin, Nazmiye Selin Salici, Vildan Manav Bas, Müge Göre Karali, Ecem Zeliha Ergün, Elif Bal Avcı, Ebru Sarıkaya Tellal, Esma Inan Yüksel, Günel Rasulova, Duygu Erdil
Introduction: Adult female acne is a chronic condition that significantly impacts quality of life. The content on social media can influence patients perception of their disease and serve as a channel through which they may seek or obtain treatment options.
Objectives: This study aims to evaluate the impact of social media usage habits on treatment decisions among adult female acne patients.
Methods: A cross-sectional, multicenter survey study involved 358 females aged 25 or above, diagnosed with acne. Sociodemographic data were collected, and social media behavior, treatment choices, outcomes, and motivation were explored.
Results: Among 358 participants, 95.3% used at least 1 social media platform; 72.1% sought acne information online. Top platforms used to seek acne information were Google (75.6%), Instagram (72.3%), YouTube (60%), and TikTok (29.4%). For advice, 67.4% consulted doctor accounts, 53.5% non-medical influencers, 53.5% patient accounts, and 36.1% product promotion accounts. Commonly followed advice included skincare products (88%), dietary changes (42.3%), home remedies (38.8%), exercise (30.3%), topical medications (25.2%), and dietary supplements (17.4%). Notably, 20.9% were willing to alter prescribed treatment by their physician for acne based on social media advice. Patient motivations included quick information access (84.1%) and difficulty in securing dermatologist appointments (54.3%).
Conclusions: The study reveals widespread social media use among adult female acne patients, highlighting concerns about potentially misleading information. Dermatologists can enhance the impact of social media by providing reliable sources for patients.
{"title":"Influence of Social Media and Internet on Treatment Decisions in Adult Female Acne Patients: A Cross-Sectional Survey Study.","authors":"Sümeyre Seda Ertekin, Nazmiye Selin Salici, Vildan Manav Bas, Müge Göre Karali, Ecem Zeliha Ergün, Elif Bal Avcı, Ebru Sarıkaya Tellal, Esma Inan Yüksel, Günel Rasulova, Duygu Erdil","doi":"10.5826/dpc.1403a156","DOIUrl":"10.5826/dpc.1403a156","url":null,"abstract":"<p><strong>Introduction: </strong>Adult female acne is a chronic condition that significantly impacts quality of life. The content on social media can influence patients perception of their disease and serve as a channel through which they may seek or obtain treatment options.</p><p><strong>Objectives: </strong>This study aims to evaluate the impact of social media usage habits on treatment decisions among adult female acne patients.</p><p><strong>Methods: </strong>A cross-sectional, multicenter survey study involved 358 females aged 25 or above, diagnosed with acne. Sociodemographic data were collected, and social media behavior, treatment choices, outcomes, and motivation were explored.</p><p><strong>Results: </strong>Among 358 participants, 95.3% used at least 1 social media platform; 72.1% sought acne information online. Top platforms used to seek acne information were Google (75.6%), Instagram (72.3%), YouTube (60%), and TikTok (29.4%). For advice, 67.4% consulted doctor accounts, 53.5% non-medical influencers, 53.5% patient accounts, and 36.1% product promotion accounts. Commonly followed advice included skincare products (88%), dietary changes (42.3%), home remedies (38.8%), exercise (30.3%), topical medications (25.2%), and dietary supplements (17.4%). Notably, 20.9% were willing to alter prescribed treatment by their physician for acne based on social media advice. Patient motivations included quick information access (84.1%) and difficulty in securing dermatologist appointments (54.3%).</p><p><strong>Conclusions: </strong>The study reveals widespread social media use among adult female acne patients, highlighting concerns about potentially misleading information. Dermatologists can enhance the impact of social media by providing reliable sources for patients.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11314130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicoleta Neagu, Caterina Dianzani, Gianluca Avallone, Iris Zalaudek, Domenico Piccolo, Giovanni Pellacani, Sebastian Laspina, Claudio Conforti
{"title":"Dermatoscopic Changes in Melanocytic Nevi After Intense Pulsed Light Treatment for Hair Removal: A Case Series.","authors":"Nicoleta Neagu, Caterina Dianzani, Gianluca Avallone, Iris Zalaudek, Domenico Piccolo, Giovanni Pellacani, Sebastian Laspina, Claudio Conforti","doi":"10.5826/dpc.1403a162","DOIUrl":"10.5826/dpc.1403a162","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11313561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annunziata Dattola, Nicoletta Bernardini, Giacomo Caldarola, Rosa Coppola, Clara De Simone, Domenico Giordano, Alessandro Giunta, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Severino Persechino, Concetta Potenza, Federica Trovato, Arianna Zangrilli, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Antonio Giovanni Richetta
Introduction: This was an observational, retrospective, multicenter study, enrolling elderly patients (>65 years old) treated with ixekizumab with a diagnosis of psoriasis (PsO) and/or psoriatic arthritis (PsA) during the period 2020 to 2023.
Objectives: Efficacy of ixekizumab in elderly patients in the treatment of moderate to severe psoriasis.
Methods: We included 73 patients with psoriasis (32.9%), psoriatic arthritis (1.4%) and both of them (PsO-PsA 65.8%), attending the outpatient clinics of seven Italian referral center for psoriasis in Lazio region: Policlinico Umberto I Università Roma La Sapienza, Sant'Andrea Università di Roma La Sapienza, Polo Pontino Università Roma La Sapienza, Fondazione Policlinico Universitario A. Gemelli, Università Campus Biomedico Roma, Istituto Dermopatico dell'Immacolata - IDI and Policlinico Tor Vergata. We collected data related to the characteristics of the patients (age, sex, body mass index) and of the disease (age at onset, duration of psoriasis, previous treatments). The severity of psoriasis was measured with the Psoriasis Area and Severity Index (PASI) score at baseline and after 16, 24, 52, 104 and 156 weeks of treatment.
Results: PASI90 was achieved by all the patients in week 16 and remained stable until the end of the study. PASI100 has been achieved by 55.1% of patients at weeks 16 and by 81.3% at week 104. A statistically significant difference has been showed between baseline and all the other time points (P < 0.0001) for PASI score. A similar trend was observed for Visual Analogue Scale score and Dermatology Life Quality Index score.
Conclusions: Ixekizumab was effective and with a good safety profile in psoriatic patients over 65 years. No significant adverse events were reported.
简介这是一项观察性、回顾性、多中心研究,纳入了2020年至2023年期间诊断为银屑病(PsO)和/或银屑病关节炎(PsA)并接受ixekizumab治疗的老年患者(年龄大于65岁):ixekizumab治疗中重度银屑病对老年患者的疗效:我们纳入了 73 名银屑病患者(32.9%)、银屑病关节炎患者(1.4%)以及同时患有银屑病关节炎和银屑病关节炎的患者(PsO-PsA 65.8%),这些患者在意大利拉齐奥大区的七个银屑病转诊中心门诊就诊:这些中心是:罗马拉萨皮恩扎大学翁贝托一世医院(Policlinico Umberto I Università Roma La Sapienza)、罗马拉萨皮恩扎圣安德烈亚大学(Sant'Andrea Università di Roma La Sapienza)、罗马拉萨皮恩扎波罗庞蒂诺大学(Polo Pontino Università Roma La Sapienza)、A. Gemelli 大学医院基金会(Fondazione Policlinico Universitario A. Gemelli)、罗马生物医学大学校园(Università Campus Biomedico Roma)、Istituto Dermopatico dell'Immacolata - IDI 和 Tor Vergata 医院。我们收集了有关患者特征(年龄、性别、体重指数)和疾病特征(发病年龄、银屑病持续时间、既往治疗情况)的数据。银屑病的严重程度在基线和治疗 16 周、24 周、52 周、104 周和 156 周后用银屑病面积和严重程度指数(PASI)评分来衡量:所有患者在第 16 周都达到了 PASI90,并在研究结束前保持稳定。55.1%的患者在第 16 周达到了 PASI100,81.3%的患者在第 104 周达到了 PASI100。在基线和所有其他时间点之间,PASI 评分均显示出明显的统计学差异(P < 0.0001)。视觉模拟量表评分和皮肤科生活质量指数评分也有类似趋势:结论:伊克珠单抗对65岁以上的银屑病患者有效,且安全性良好。无重大不良反应报告。
{"title":"Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.","authors":"Annunziata Dattola, Nicoletta Bernardini, Giacomo Caldarola, Rosa Coppola, Clara De Simone, Domenico Giordano, Alessandro Giunta, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Severino Persechino, Concetta Potenza, Federica Trovato, Arianna Zangrilli, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Antonio Giovanni Richetta","doi":"10.5826/dpc.1403a166","DOIUrl":"10.5826/dpc.1403a166","url":null,"abstract":"<p><strong>Introduction: </strong>This was an observational, retrospective, multicenter study, enrolling elderly patients (>65 years old) treated with ixekizumab with a diagnosis of psoriasis (PsO) and/or psoriatic arthritis (PsA) during the period 2020 to 2023.</p><p><strong>Objectives: </strong>Efficacy of ixekizumab in elderly patients in the treatment of moderate to severe psoriasis.</p><p><strong>Methods: </strong>We included 73 patients with psoriasis (32.9%), psoriatic arthritis (1.4%) and both of them (PsO-PsA 65.8%), attending the outpatient clinics of seven Italian referral center for psoriasis in Lazio region: Policlinico Umberto I Università Roma La Sapienza, Sant'Andrea Università di Roma La Sapienza, Polo Pontino Università Roma La Sapienza, Fondazione Policlinico Universitario A. Gemelli, Università Campus Biomedico Roma, Istituto Dermopatico dell'Immacolata - IDI and Policlinico Tor Vergata. We collected data related to the characteristics of the patients (age, sex, body mass index) and of the disease (age at onset, duration of psoriasis, previous treatments). The severity of psoriasis was measured with the Psoriasis Area and Severity Index (PASI) score at baseline and after 16, 24, 52, 104 and 156 weeks of treatment.</p><p><strong>Results: </strong>PASI90 was achieved by all the patients in week 16 and remained stable until the end of the study. PASI100 has been achieved by 55.1% of patients at weeks 16 and by 81.3% at week 104. A statistically significant difference has been showed between baseline and all the other time points (P < 0.0001) for PASI score. A similar trend was observed for Visual Analogue Scale score and Dermatology Life Quality Index score.</p><p><strong>Conclusions: </strong>Ixekizumab was effective and with a good safety profile in psoriatic patients over 65 years. No significant adverse events were reported.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11314344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life has been poorly investigated.
Objectives: Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified Palmoplantar Pustular Psoriasis Area and Severity Index (m-PPPASI), and to evaluate the correlation with the Dermatology Life Quality Index (DLQI).
Methods: We conducted a descriptive study with prospective data collection from January to June 2021. We enrolled 223 patients with psoriasis. We excluded patients without palmar/plantar involvement and those with a body surface area (BSA) greater than or equal to 10%.
Results: We included 33 patients with PPP. This corresponded to a 14.8% prevalence among all psoriasis phenotypes. The mean age was 45 years. The male-to-female ratio was 2.3. Pruritus was present in 27 cases. The mean m-PPPASI was 11.77. The mean DLQI was 8.33. A significant correlation was found between DLQI and m-PPPASI: mean DLQI scores for patients with m-PPPASI less than or equal to 10 and m-PPPASI greater than 10 were 5.6 and 11.3, respectively (P = 0.002). Only 11.8% of patients with m-PPPASI less than or equal to 10 had a DLQI greater than 10, whereas 50% of those with m-PPPASI greater than 10 had a DLQI greater than 10 (P = 0.026).
Conclusions: Based on the present work, we confirm that, although affecting a reduced BSA, PPP is a severe form of psoriasis. We consider the m-PPPASI to be a reliable tool which can be used to assess the severity of PPP.
{"title":"Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life.","authors":"Dorsaf Elinkichari, Faten Rabhi, Kahena Jaber, Raouf Dhaoui","doi":"10.5826/dpc.1403a191","DOIUrl":"10.5826/dpc.1403a191","url":null,"abstract":"<p><strong>Introduction: </strong>Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life has been poorly investigated.</p><p><strong>Objectives: </strong>Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified Palmoplantar Pustular Psoriasis Area and Severity Index (m-PPPASI), and to evaluate the correlation with the Dermatology Life Quality Index (DLQI).</p><p><strong>Methods: </strong>We conducted a descriptive study with prospective data collection from January to June 2021. We enrolled 223 patients with psoriasis. We excluded patients without palmar/plantar involvement and those with a body surface area (BSA) greater than or equal to 10%.</p><p><strong>Results: </strong>We included 33 patients with PPP. This corresponded to a 14.8% prevalence among all psoriasis phenotypes. The mean age was 45 years. The male-to-female ratio was 2.3. Pruritus was present in 27 cases. The mean m-PPPASI was 11.77. The mean DLQI was 8.33. A significant correlation was found between DLQI and m-PPPASI: mean DLQI scores for patients with m-PPPASI less than or equal to 10 and m-PPPASI greater than 10 were 5.6 and 11.3, respectively (P = 0.002). Only 11.8% of patients with m-PPPASI less than or equal to 10 had a DLQI greater than 10, whereas 50% of those with m-PPPASI greater than 10 had a DLQI greater than 10 (P = 0.026).</p><p><strong>Conclusions: </strong>Based on the present work, we confirm that, although affecting a reduced BSA, PPP is a severe form of psoriasis. We consider the m-PPPASI to be a reliable tool which can be used to assess the severity of PPP.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11314393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abdullah Alakeel, Abeer Alkahtani, Rahaf Alshareef, Norah Almajli, Khalid Alekrish
Introduction: Corticophobia constitutes a complex challenge affecting patients and healthcare professionals alike, resulting in suboptimal management and treatment of dermatological conditions.
Objectives: This study aims to investigate corticophobia among physicians in Saudi Arabia and identify associated factors.
Methods: This is a retrospective, observational, cross-sectional study that included 700 participants. The sample constituted dermatologists, pediatricians, and family medicine practitioners at different levels (consultants, fellows, and residents) in Saudi Arabia. Data were collected via an electronic survey addressing demographic information and corticophobia-related questions.
Results: A total of 700 participants were included in the data analysis. Dermatologists were the most comfortable prescribing steroids (32%), followed by family medicine physicians (25%), and pediatricians (18%). Pediatricians were the most hesitant to prescribe steroids. Fellows were the most confident in prescribing steroids. Physicians from the northern and western regions were least likely to be hesitant in prescribing steroids.
Conclusions: In conclusion, this study reveals that in Saudi Arabia, dermatologists were the most comfortable prescribing topical corticosteroids, with pediatricians being the most hesitant. The findings emphasize the importance of education in addressing corticophobia among healthcare professionals, which could improve treatment adherence and patient outcomes. Further research and targeted educational interventions are necessary to enhance understanding and confidence in prescribing topical corticosteroids among healthcare professionals.
{"title":"Topical Corticophobia Among Healthcare Professionals in Saudi Arabia: A Cross-Sectional Study.","authors":"Abdullah Alakeel, Abeer Alkahtani, Rahaf Alshareef, Norah Almajli, Khalid Alekrish","doi":"10.5826/dpc.1403a106","DOIUrl":"10.5826/dpc.1403a106","url":null,"abstract":"<p><strong>Introduction: </strong>Corticophobia constitutes a complex challenge affecting patients and healthcare professionals alike, resulting in suboptimal management and treatment of dermatological conditions.</p><p><strong>Objectives: </strong>This study aims to investigate corticophobia among physicians in Saudi Arabia and identify associated factors.</p><p><strong>Methods: </strong>This is a retrospective, observational, cross-sectional study that included 700 participants. The sample constituted dermatologists, pediatricians, and family medicine practitioners at different levels (consultants, fellows, and residents) in Saudi Arabia. Data were collected via an electronic survey addressing demographic information and corticophobia-related questions.</p><p><strong>Results: </strong>A total of 700 participants were included in the data analysis. Dermatologists were the most comfortable prescribing steroids (32%), followed by family medicine physicians (25%), and pediatricians (18%). Pediatricians were the most hesitant to prescribe steroids. Fellows were the most confident in prescribing steroids. Physicians from the northern and western regions were least likely to be hesitant in prescribing steroids.</p><p><strong>Conclusions: </strong>In conclusion, this study reveals that in Saudi Arabia, dermatologists were the most comfortable prescribing topical corticosteroids, with pediatricians being the most hesitant. The findings emphasize the importance of education in addressing corticophobia among healthcare professionals, which could improve treatment adherence and patient outcomes. Further research and targeted educational interventions are necessary to enhance understanding and confidence in prescribing topical corticosteroids among healthcare professionals.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11313543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Guerriero, Simone Cappilli, Francesco Tassone, Gerardo Palmisano, Alessandro Di Stefani, Ketty Peris
{"title":"Seven-Year Follow-Up of a Congenital Nail Matrix Nevus.","authors":"Cristina Guerriero, Simone Cappilli, Francesco Tassone, Gerardo Palmisano, Alessandro Di Stefani, Ketty Peris","doi":"10.5826/dpc.1403a207","DOIUrl":"https://doi.org/10.5826/dpc.1403a207","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria Francesca Baracca, Luca Rapparini, Michela Starace, Iria Neri, Bianca Maria Piraccini
{"title":"Nail Changes and Periungual Dermatitis in a Finger of a Seven-Year-Old Girl.","authors":"Maria Francesca Baracca, Luca Rapparini, Michela Starace, Iria Neri, Bianca Maria Piraccini","doi":"10.5826/dpc.1403a209","DOIUrl":"https://doi.org/10.5826/dpc.1403a209","url":null,"abstract":"","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}